SEC Form 4 · accession 0001179110-16-019707
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard P Shea
Officer — SVP, CFO
Period of report
Feb 19, 2016
Accepted (ET)
Feb 22, 2016 · 12:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 19, 2016 | S | 404 | $9.65 | D | 141,924 | D | |
| Common Stock | Feb 19, 2016 | S | 1,419 | $9.64 | D | 140,505 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2008.